RITUXIMAB

RITUXIMAB was reported 214104 times

RITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5866 0.8179
1 PEMPHIGUS 9533 0.7617
2 RED BLOOD CELL SEDIMENTATION RATE 211 0.7563
3 SWOLLEN JOINT COUNT INCREASED 2385 0.7472
4 RHEUMATIC FEVER 3300 0.7396
5 VACCINE INTERACTION 228 0.7355
6 RHEUMATOID FACTOR POSITIVE 4241 0.7335
7 SWOLLEN JOINT COUNT 182 0.7280
8 C-REACTIVE PROTEIN 659 0.7109
9 LUPUS VULGARIS 881 0.6992
10 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1513 0.6855
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 1366 0.6820
12 DUODENAL ULCER PERFORATION 5058 0.6795
13 FACET JOINT SYNDROME 2099 0.6441
14 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 417 0.6243
15 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 435 0.6241
16 GRANULOMA SKIN 507 0.6175
17 GRIP STRENGTH 140 0.6114
18 MANTLE CELL LYMPHOMA RECURRENT 265 0.6092
19 B-CELL LYMPHOMA RECURRENT 327 0.6022
20 BLOOD PRESSURE DIASTOLIC ABNORMAL 1523 0.5982
21 HAND DEFORMITY 7832 0.5965
22 LYMPHOMA TRANSFORMATION 214 0.5944
23 BLOOD PRESSURE SYSTOLIC ABNORMAL 1416 0.5724
24 HUMORAL IMMUNE DEFECT 208 0.5606
25 X-RAY ABNORMAL 987 0.5514
26 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1126 0.5429
27 HELICOBACTER INFECTION 5186 0.5041
28 DISLOCATION OF VERTEBRA 1144 0.5011
29 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 468 0.4942
30 SYNOVITIS 8911 0.4937
31 C-REACTIVE PROTEIN ABNORMAL 3112 0.4847
32 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 266 0.4742
33 HYPOCHOLESTEROLAEMIA 166 0.4703
34 FOLLICULAR LYMPHOMA 405 0.4602
35 MUSCLE INJURY 3817 0.4602
36 RETINITIS 768 0.4442
37 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2759 0.4244
38 FOLLICULITIS 4429 0.4219
39 PERIPHERAL VENOUS DISEASE 1675 0.4097
40 BLOOD PARATHYROID HORMONE DECREASED 588 0.3965
41 PERICARDITIS 6370 0.3788
42 GLOSSODYNIA 8478 0.3783
43 GRANULOMATOSIS WITH POLYANGIITIS 445 0.3687
44 NEUROLOGIC NEGLECT SYNDROME 197 0.3543
45 DRUG TOLERANCE DECREASED 995 0.3540
46 BONE EROSION 1243 0.3511
47 CONTRAINDICATED PRODUCT ADMINISTERED 10532 0.3475
48 UREAPLASMA INFECTION 138 0.3382
49 HYPOGAMMAGLOBULINAEMIA 2171 0.3301
50 ENCEPHALITIS CYTOMEGALOVIRUS 142 0.3242
51 B-LYMPHOCYTE COUNT DECREASED 421 0.3091
52 RHEUMATOID NODULE 834 0.3025
53 SERONEGATIVE ARTHRITIS 341 0.2976
54 HEPATITIS B REACTIVATION 938 0.2952
55 MANTLE CELL LYMPHOMA 443 0.2909
56 PANNICULITIS 694 0.2865
57 SYSTEMIC LUPUS ERYTHEMATOSUS 9843 0.2770
58 OVERLAP SYNDROME 188 0.2686
59 BREAST CANCER STAGE III 1721 0.2655
60 CENTRAL NERVOUS SYSTEM LYMPHOMA 366 0.2654
61 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 607 0.2632
62 WOUND 7297 0.2608
63 DIFFUSE LARGE B-CELL LYMPHOMA 2001 0.2594
64 MENINGITIS TUBERCULOUS 142 0.2540
65 CAROTID ARTERY THROMBOSIS 211 0.2485
66 VACCINATION FAILURE 411 0.2470
67 PORPHYRIA ACUTE 346 0.2411
68 LIP DRY 2139 0.2353
69 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 308 0.2339
70 NEUROMYELITIS OPTICA SPECTRUM DISORDER 313 0.2320
71 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2535 0.2289
72 ONYCHOMADESIS 959 0.2283
73 GRIP STRENGTH DECREASED 2005 0.2276
74 JOINT DESTRUCTION 352 0.2262
75 BURSITIS 2693 0.2217
76 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1823 0.2208
77 PNEUMOCYSTIS JIROVECII INFECTION 259 0.2167
78 TEMPERATURE REGULATION DISORDER 483 0.2166
79 BLOOD IMMUNOGLOBULIN A DECREASED 139 0.2135
80 JC VIRUS INFECTION 339 0.2119
81 JOINT RANGE OF MOTION DECREASED 2804 0.2089
82 EPSTEIN-BARR VIRAEMIA 231 0.2083
83 CRYOGLOBULINAEMIA 147 0.2056
84 SECONDARY IMMUNODEFICIENCY 245 0.2016
85 WOUND INFECTION 2200 0.2007
86 IRRITABLE BOWEL SYNDROME 4205 0.1959
87 ONYCHOMYCOSIS 859 0.1956
88 CYTOMEGALOVIRUS INFECTION REACTIVATION 858 0.1940
89 INFUSION RELATED REACTION 12870 0.1940
90 HYPERCHOLESTEROLAEMIA 1814 0.1877
91 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 956 0.1876
92 BLOOD IMMUNOGLOBULIN M DECREASED 183 0.1825
93 RHEUMATOID ARTHRITIS 20327 0.1789
94 LIVE BIRTH 1461 0.1745
95 FINGER DEFORMITY 842 0.1736
96 PSEUDOMONAL BACTERAEMIA 145 0.1698
97 NASAL OEDEMA 306 0.1692
98 ARTHROPATHY 9376 0.1685
99 ASPERGILLUS INFECTION 1104 0.1680
100 SERUM SICKNESS 467 0.1674
101 NEUTROPENIC INFECTION 157 0.1641
102 BLEPHAROSPASM 1034 0.1640
103 FIBROMYALGIA 3933 0.1616
104 TUMOUR LYSIS SYNDROME 1409 0.1600
105 LUPUS NEPHRITIS 291 0.1554
106 EAR PRURITUS 543 0.1547
107 ADJUSTMENT DISORDER 200 0.1538
108 AUTOIMMUNE DISORDER 1501 0.1538
109 THERAPEUTIC PRODUCT EFFECT DECREASED 6850 0.1528
110 PHARYNGEAL PARAESTHESIA 242 0.1524
111 NAIL DISORDER 1327 0.1515
112 HEPATITIS B 896 0.1485
113 MATERNAL EXPOSURE TIMING UNSPECIFIED 557 0.1481
114 CHRONIC LYMPHOCYTIC LEUKAEMIA 685 0.1442
115 LIVER INJURY 3541 0.1441
116 TENOSYNOVITIS 396 0.1434
117 PNEUMOCYSTIS JIROVECII PNEUMONIA 1428 0.1421
118 BLOOD PRESSURE DIASTOLIC DECREASED 1048 0.1418
119 SUSPECTED OFF LABEL USE 633 0.1400
120 PNEUMONIA CYTOMEGALOVIRAL 272 0.1399
121 INFUSION SITE REACTION 418 0.1398
122 ADENOVIRUS INFECTION 404 0.1392
123 COVID-19 PNEUMONIA 1632 0.1381
124 PULMONARY FIBROSIS 2633 0.1371
125 CYTOMEGALOVIRUS CHORIORETINITIS 266 0.1363
126 IMPAIRED HEALING 4461 0.1357
127 POST-ACUTE COVID-19 SYNDROME 165 0.1332
128 DRUG INTOLERANCE 12675 0.1311
129 BLOOD IMMUNOGLOBULIN G DECREASED 325 0.1310
130 OBLITERATIVE BRONCHIOLITIS 171 0.1302
131 BK VIRUS INFECTION 439 0.1300
132 COELIAC DISEASE 1276 0.1300
133 ENCEPHALITIS VIRAL 158 0.1297
134 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 304 0.1296
135 HEPATITIS E 204 0.1291
136 SOFT TISSUE DISORDER 143 0.1289
137 POLYOMAVIRUS VIRAEMIA 135 0.1271
138 SCIATICA 2013 0.1261
139 B-CELL LYMPHOMA 427 0.1256
140 C-REACTIVE PROTEIN INCREASED 4525 0.1242
141 CYTOPENIA 1507 0.1230
142 TYPE 2 DIABETES MELLITUS 4143 0.1229
143 FEBRILE NEUTROPENIA 8129 0.1224
144 BLOOD PRESSURE SYSTOLIC INCREASED 2380 0.1219
145 HEPATIC ENZYME INCREASED 8311 0.1218
146 DEATH NEONATAL 167 0.1200
147 AUTOIMMUNE HAEMOLYTIC ANAEMIA 411 0.1198
148 CYTOMEGALOVIRUS VIRAEMIA 533 0.1197
149 TREATMENT FAILURE 9921 0.1196
150 CYTOMEGALOVIRUS INFECTION 1990 0.1196
151 ENTHESOPATHY 187 0.1195
152 IMMUNOGLOBULINS DECREASED 164 0.1194
153 OBESITY 1896 0.1189
154 BLOOD PRESSURE DIASTOLIC INCREASED 541 0.1171
155 EPSTEIN-BARR VIRUS INFECTION 732 0.1170
156 PNEUMOCYSTIS JIROVECI PNEUMONIA 260 0.1166
157 FOOT DEFORMITY 1280 0.1154
158 SKIN NECROSIS 591 0.1138
159 PSORIATIC ARTHROPATHY 4582 0.1128
160 VARICELLA ZOSTER VIRUS INFECTION 233 0.1123
161 PRODUCT LABEL CONFUSION 652 0.1118
162 NEUTROPENIC SEPSIS 786 0.1099
163 LOWER RESPIRATORY TRACT INFECTION 4950 0.1087
164 STEROID DIABETES 163 0.1086
165 CONTRAST MEDIA ALLERGY 198 0.1080
166 PRESCRIBED OVERDOSE 2092 0.1080
167 INTENTIONAL PRODUCT USE ISSUE 9465 0.1079
168 HAEMATOTOXICITY 1025 0.1078
169 BRONCHOPULMONARY ASPERGILLOSIS 814 0.1049
170 STRONGYLOIDIASIS 169 0.1045
171 STAPHYLOCOCCAL BACTERAEMIA 453 0.1041
172 EXOSTOSIS 915 0.1001
173 MYELODYSPLASTIC SYNDROME 1445 0.0998
174 SWELLING 9348 0.0998
175 HIP ARTHROPLASTY 1527 0.0996
176 JOINT SWELLING 12000 0.0993
177 BACK INJURY 1075 0.0988
178 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 173 0.0978
179 CYTOMEGALOVIRUS TEST POSITIVE 173 0.0970
180 IMMUNE THROMBOCYTOPENIA 441 0.0962
181 HUMAN HERPESVIRUS 6 INFECTION 182 0.0962
182 DISCOMFORT 5869 0.0961
183 IMMUNODEFICIENCY 1406 0.0942
184 CYTOKINE RELEASE SYNDROME 1886 0.0939
185 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 198 0.0930
186 DEMYELINATION 380 0.0926
187 LYMPHOMA 1424 0.0920
188 THERAPY PARTIAL RESPONDER 1414 0.0906
189 DRUG TOLERANCE 456 0.0900
190 CUSHINGOID 288 0.0896
191 WALKING AID USER 591 0.0895
192 MEAN CELL HAEMOGLOBIN DECREASED 164 0.0895
193 BLOOD PRESSURE FLUCTUATION 2144 0.0892
194 MONOCYTE COUNT INCREASED 323 0.0889
195 BLOOD CHOLESTEROL INCREASED 4133 0.0886
196 STOMATITIS 5361 0.0883
197 APPARENT DEATH 316 0.0877
198 SYSTEMIC CANDIDA 219 0.0871
199 ENTEROCOCCAL INFECTION 421 0.0870
200 MEAN CELL VOLUME DECREASED 134 0.0868
201 OSTEOARTHRITIS 3671 0.0865
202 JOINT ARTHROPLASTY 155 0.0865
203 ALANINE AMINOTRANSFERASE ABNORMAL 182 0.0862
204 PNEUMONIA VIRAL 272 0.0852
205 ESCHERICHIA BACTERAEMIA 200 0.0850
206 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 136 0.0848
207 PSEUDOMONAL SEPSIS 148 0.0844
208 CHRONIC GRAFT VERSUS HOST DISEASE 305 0.0844
209 LOWER LIMB FRACTURE 1621 0.0843
210 PNEUMONIA KLEBSIELLA 155 0.0842
211 FOOD ALLERGY 649 0.0840
212 BLISTER 4691 0.0834
213 INTERVERTEBRAL DISCITIS 157 0.0832
214 LUPUS-LIKE SYNDROME 751 0.0827
215 SCLERITIS 132 0.0823
216 SECOND PRIMARY MALIGNANCY 685 0.0823
217 GLOMERULONEPHRITIS 199 0.0812
218 LYMPHOPENIA 1149 0.0812
219 CYTOMEGALOVIRUS COLITIS 186 0.0808
220 BRONCHITIS CHRONIC 197 0.0806
221 POLYARTHRITIS 424 0.0803
222 PUSTULAR PSORIASIS 275 0.0800
223 GAIT INABILITY 2669 0.0798
224 FEBRILE BONE MARROW APLASIA 339 0.0797
225 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 212 0.0796
226 INFLAMMATION 4083 0.0790
227 ORGANISING PNEUMONIA 391 0.0788
228 KNEE ARTHROPLASTY 1660 0.0788
229 ILL-DEFINED DISORDER 4772 0.0785
230 CYSTITIS HAEMORRHAGIC 316 0.0783
231 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 193 0.0780
232 INFECTION 11292 0.0779
233 BACTERIAL SEPSIS 253 0.0776
234 GRAFT VERSUS HOST DISEASE IN SKIN 171 0.0776
235 LYMPHADENITIS 187 0.0771
236 GASTROINTESTINAL TOXICITY 369 0.0767
237 LYMPHOCYTOSIS 165 0.0766
238 KLEBSIELLA INFECTION 387 0.0765
239 PNEUMONIA FUNGAL 301 0.0762
240 PERSONALITY DISORDER 199 0.0759
241 MATERNAL EXPOSURE DURING PREGNANCY 6758 0.0757
242 PRESCRIBED UNDERDOSE 1508 0.0755
243 HYPERCALCAEMIA 928 0.0751
244 MUSCULOSKELETAL STIFFNESS 6557 0.0748
245 NIGHT SWEATS 2403 0.0745
246 LIVER FUNCTION TEST INCREASED 1601 0.0745
247 THERAPY NON-RESPONDER 3332 0.0741
248 BREAST CANCER STAGE II 615 0.0738
249 OPPORTUNISTIC INFECTION 136 0.0735
250 PULMONARY TOXICITY 518 0.0732
251 WHEEZING 4310 0.0726
252 EMPYEMA 144 0.0724
253 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 428 0.0722
254 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 199 0.0719
255 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 530 0.0706
256 BASAL CELL CARCINOMA 1095 0.0701
257 OEDEMA 3801 0.0700
258 ULCER HAEMORRHAGE 471 0.0695
259 ESCHERICHIA SEPSIS 201 0.0693
260 BACTERAEMIA 817 0.0688
261 ORAL PRURITUS 158 0.0688
262 DERMATOMYOSITIS 173 0.0682
263 TRANSPLANT REJECTION 543 0.0677
264 EYE INJURY 205 0.0674
265 MOBILITY DECREASED 4841 0.0673
266 DISEASE PROGRESSION 7956 0.0672
267 ARTHRITIS BACTERIAL 275 0.0669
268 FINE MOTOR SKILL DYSFUNCTION 192 0.0663
269 PSEUDOMONAS INFECTION 567 0.0661
270 BLOOD LACTATE DEHYDROGENASE INCREASED 1046 0.0659
271 FOETAL DEATH 341 0.0657
272 LUNG DISORDER 3191 0.0650
273 MUCOSAL INFLAMMATION 1685 0.0643
274 MUCORMYCOSIS 167 0.0642
275 JOINT DISLOCATION 674 0.0637
276 RASH VESICULAR 304 0.0628
277 ACUTE MYELOID LEUKAEMIA 979 0.0628
278 ABDOMINAL DISCOMFORT 10499 0.0625
279 NEUTROPENIA 8422 0.0619
280 MUSCULOSKELETAL PAIN 3234 0.0617
281 HERPES SIMPLEX 393 0.0604
282 AGRANULOCYTOSIS 1122 0.0603
283 VASCULITIS 702 0.0602
284 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 575 0.0602
285 STAPHYLOCOCCAL SEPSIS 296 0.0599
286 CONGENITAL ANOMALY 464 0.0599
287 NOCARDIOSIS 152 0.0594
288 SEPTIC SHOCK 2585 0.0593
289 PNEUMONIA BACTERIAL 545 0.0593
290 VENOOCCLUSIVE LIVER DISEASE 288 0.0583
291 CARDIOTOXICITY 519 0.0581
292 IMMUNOSUPPRESSION 505 0.0572
293 JOINT STIFFNESS 1491 0.0568
294 ULCER 904 0.0568
295 GASTROINTESTINAL DISORDER 5079 0.0566
296 BODY TEMPERATURE DECREASED 558 0.0566
297 LYMPHOPROLIFERATIVE DISORDER 166 0.0565
298 APLASIA PURE RED CELL 193 0.0560
299 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2688 0.0559
300 THROMBOTIC THROMBOCYTOPENIC PURPURA 197 0.0559
301 HEPATIC CIRRHOSIS 1050 0.0558
302 ALOPECIA 10955 0.0557
303 ACUTE GRAFT VERSUS HOST DISEASE 255 0.0557
304 GENERAL PHYSICAL HEALTH DETERIORATION 6383 0.0551
305 WHITE BLOOD CELL COUNT ABNORMAL 350 0.0548
306 CREPITATIONS 163 0.0547
307 THROMBOCYTOPENIA 6115 0.0546
308 TRANSPLANT FAILURE 134 0.0546
309 INTERSTITIAL LUNG DISEASE 2636 0.0544
310 BONE MARROW FAILURE 1104 0.0543
311 NORMAL NEWBORN 295 0.0542
312 PANCYTOPENIA 3031 0.0542
313 SPONDYLITIS 197 0.0541
314 RESPIRATORY TRACT INFECTION 1405 0.0539
315 RHINOVIRUS INFECTION 207 0.0531
316 LIVER DISORDER 2358 0.0531
317 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1495 0.0527
318 GRANULOMA 182 0.0525
319 LEUKOPENIA 2617 0.0523
320 TASTE DISORDER 1058 0.0521
321 JOINT EFFUSION 359 0.0520
322 SINUSITIS 5327 0.0519
323 BLOOD PRESSURE SYSTOLIC DECREASED 235 0.0516
324 NEOPLASM RECURRENCE 173 0.0510
325 HYPERURICAEMIA 209 0.0508
326 HYPERSENSITIVITY 9396 0.0506
327 MYOSITIS 453 0.0504
328 INJURY 3542 0.0503
329 OXYGEN SATURATION DECREASED 2824 0.0502
330 SYNOVIAL CYST 232 0.0502
331 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1467 0.0500
332 GRAFT VERSUS HOST DISEASE 359 0.0499
333 HISTIOCYTOSIS HAEMATOPHAGIC 148 0.0498
334 ENCEPHALITIS 344 0.0497
335 SARCOIDOSIS 236 0.0496
336 HEPATITIS 1269 0.0495
337 SLEEP DISORDER 3488 0.0494
338 SKIN ULCER 1271 0.0491
339 NEPHROTIC SYNDROME 336 0.0490
340 RED CELL DISTRIBUTION WIDTH INCREASED 203 0.0488
341 BRONCHIECTASIS 327 0.0485
342 IMMUNE THROMBOCYTOPENIC PURPURA 137 0.0484
343 VENOUS THROMBOSIS 189 0.0481
344 KIDNEY TRANSPLANT REJECTION 231 0.0481
345 GANGRENE 289 0.0479
346 THYROID NEOPLASM 132 0.0478
347 ESCHERICHIA URINARY TRACT INFECTION 203 0.0477
348 ADVERSE REACTION 632 0.0476
349 OFF LABEL USE 41722 0.0476
350 LUNG ADENOCARCINOMA 142 0.0471
351 NEUTROPHIL COUNT DECREASED 1914 0.0469
352 THROMBOTIC MICROANGIOPATHY 455 0.0466
353 LYMPHOCYTE COUNT DECREASED 824 0.0466
354 HEART RATE DECREASED 1624 0.0462
355 RESPIRATORY RATE INCREASED 410 0.0461
356 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 791 0.0461
357 EXPOSURE DURING PREGNANCY 2862 0.0460
358 CANDIDA INFECTION 777 0.0460
359 LEUKOENCEPHALOPATHY 171 0.0459
360 PERIPHERAL SENSORY NEUROPATHY 267 0.0456
361 SEPSIS 5029 0.0450
362 ADRENAL INSUFFICIENCY 542 0.0446
363 UPPER RESPIRATORY TRACT INFECTION 2052 0.0444
364 DRUG ERUPTION 785 0.0443
365 NODULE 578 0.0442
366 ESCHERICHIA INFECTION 364 0.0442
367 SKIN INFECTION 495 0.0441
368 PERIPHERAL SWELLING 6783 0.0440
369 DEFORMITY 409 0.0437
370 INFLAMMATORY MARKER INCREASED 216 0.0435
371 HERPES ZOSTER 2478 0.0431
372 HAEMOLYSIS 333 0.0431
373 ABDOMINAL ABSCESS 190 0.0429
374 NEPHROPATHY TOXIC 482 0.0429
375 VIRAL UPPER RESPIRATORY TRACT INFECTION 203 0.0427
376 EPILEPSY 1292 0.0422
377 ROAD TRAFFIC ACCIDENT 1764 0.0421
378 SCLERODERMA 153 0.0421
379 SENSITIVITY TO WEATHER CHANGE 221 0.0420
380 DRUG-INDUCED LIVER INJURY 1314 0.0418
381 WHEELCHAIR USER 186 0.0418
382 ARTHRITIS INFECTIVE 194 0.0418
383 THROAT IRRITATION 1866 0.0415
384 MYELOSUPPRESSION 1493 0.0414
385 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2270 0.0413
386 HEPATOTOXICITY 916 0.0411
387 DELIRIUM 1427 0.0411
388 PREGNANCY 822 0.0410
389 PNEUMONIA 13256 0.0409
390 PLATELET COUNT ABNORMAL 247 0.0408
391 OSTEOPOROSIS 1673 0.0406
392 SQUAMOUS CELL CARCINOMA 378 0.0401
393 OESOPHAGEAL CANDIDIASIS 160 0.0401
394 PULMONARY ALVEOLAR HAEMORRHAGE 225 0.0401
395 UROSEPSIS 369 0.0400
396 BREATH SOUNDS ABNORMAL 197 0.0399
397 LYMPHADENOPATHY 1409 0.0398
398 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2828 0.0397
399 COVID-19 6971 0.0397
400 PRODUCT USE ISSUE 7393 0.0393
401 CONTUSION 3769 0.0391
402 ACUTE RESPIRATORY DISTRESS SYNDROME 690 0.0390
403 ACUTE HEPATIC FAILURE 526 0.0385
404 ENTEROCOLITIS 222 0.0384
405 DISABILITY 759 0.0383
406 NASOPHARYNGITIS 7070 0.0383
407 SPLENOMEGALY 448 0.0382
408 SENSORY LOSS 306 0.0380
409 ARTHRITIS 2986 0.0379
410 DISEASE RECURRENCE 1804 0.0379
411 HYPERTENSION 7960 0.0375
412 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 142 0.0371
413 HAEMOLYTIC ANAEMIA 333 0.0371
414 MUSCLE SPASTICITY 456 0.0371
415 DRY MOUTH 3000 0.0369
416 ARTERIAL OCCLUSIVE DISEASE 290 0.0369
417 PLATELET COUNT INCREASED 480 0.0368
418 HYPERTRANSAMINASAEMIA 256 0.0368
419 POLYNEUROPATHY 439 0.0366
420 VASCULAR DEVICE INFECTION 166 0.0366
421 CLOSTRIDIUM DIFFICILE COLITIS 387 0.0365
422 CHRONIC SINUSITIS 135 0.0359
423 NEUTROPHIL COUNT INCREASED 368 0.0359
424 LEFT VENTRICULAR DYSFUNCTION 238 0.0355
425 LUNG INFILTRATION 313 0.0354
426 ERYSIPELAS 178 0.0354
427 APLASTIC ANAEMIA 185 0.0354
428 PYELONEPHRITIS 306 0.0353
429 INTERCEPTED MEDICATION ERROR 163 0.0351
430 EAR PAIN 683 0.0351
431 INTESTINAL PERFORATION 394 0.0351
432 ANAPHYLACTIC REACTION 1938 0.0350
433 GENERAL SYMPTOM 262 0.0349
434 DIVERTICULITIS 967 0.0349
435 BACTERIAL INFECTION 650 0.0348
436 PYREXIA 11912 0.0344
437 EAR INFECTION 909 0.0341
438 ENDOCARDITIS 175 0.0341
439 CARDIOMYOPATHY 503 0.0340
440 PULMONARY MASS 504 0.0338
441 RESPIRATORY DISORDER 1011 0.0338
442 PNEUMONITIS 916 0.0336
443 THERAPEUTIC RESPONSE DECREASED 2034 0.0335
444 SQUAMOUS CELL CARCINOMA OF SKIN 202 0.0334
445 TONGUE DISORDER 240 0.0331
446 DRUG RESISTANCE 843 0.0328
447 NECK PAIN 1834 0.0328
448 CONDITION AGGRAVATED 9951 0.0327
449 RESPIRATORY FAILURE 2376 0.0325
450 ARTHRALGIA 13466 0.0324
451 SINUS CONGESTION 434 0.0321
452 PRODUCT USE IN UNAPPROVED INDICATION 7961 0.0321
453 EMBOLISM 265 0.0319
454 NO ADVERSE EVENT 5781 0.0319
455 MENINGITIS 213 0.0319
456 ASTHMA 3600 0.0318
457 NEOPLASM 365 0.0317
458 GUILLAIN-BARRE SYNDROME 153 0.0316
459 MENINGITIS ASEPTIC 142 0.0316
460 PROTEIN URINE PRESENT 157 0.0315
461 MUSCULOSKELETAL DISORDER 599 0.0314
462 RASH 13683 0.0314
463 NEUROTOXICITY 550 0.0314
464 FOOT OPERATION 155 0.0313
465 HYDRONEPHROSIS 234 0.0312
466 BODY TEMPERATURE INCREASED 634 0.0310
467 CONFUSIONAL STATE 5018 0.0310
468 ALANINE AMINOTRANSFERASE INCREASED 1904 0.0310
469 WEIGHT INCREASED 6928 0.0309
470 HEMIPLEGIA 256 0.0307
471 HYPOAESTHESIA 4606 0.0307
472 LUNG INFECTION 474 0.0305
473 PROTEINURIA 574 0.0302
474 PHYSICAL DISABILITY 133 0.0301
475 HERPES VIRUS INFECTION 172 0.0298
476 DEVICE RELATED INFECTION 456 0.0296
477 BLOOD URIC ACID INCREASED 171 0.0296
478 RHINITIS 238 0.0295
479 PHLEBITIS 151 0.0295
480 MYASTHENIA GRAVIS 238 0.0294
481 ACUTE PULMONARY OEDEMA 165 0.0294
482 ASPARTATE AMINOTRANSFERASE INCREASED 1557 0.0293
483 PAIN 17935 0.0292
484 MOTOR DYSFUNCTION 297 0.0291
485 PULMONARY THROMBOSIS 317 0.0290
486 NEUROLOGICAL SYMPTOM 166 0.0290
487 PLATELET COUNT DECREASED 3090 0.0290
488 DYSPEPSIA 2849 0.0289
489 ANAEMIA 5507 0.0288
490 URTICARIA 4805 0.0287
491 MUSCULAR WEAKNESS 3255 0.0286
492 METASTASIS 203 0.0284
493 POOR VENOUS ACCESS 294 0.0284
494 HYPOALBUMINAEMIA 220 0.0283
495 MOUTH ULCERATION 595 0.0282
496 APHTHOUS ULCER 218 0.0281
497 WHITE BLOOD CELL COUNT INCREASED 1068 0.0278
498 JOINT INJURY 593 0.0277
499 PULMONARY HAEMORRHAGE 217 0.0277
500 HAEMOGLOBIN ABNORMAL 177 0.0275
501 CLOSTRIDIUM DIFFICILE INFECTION 600 0.0275
502 TENDERNESS 286 0.0274
503 ORAL CANDIDIASIS 358 0.0272
504 GASTROINTESTINAL INFECTION 243 0.0271
505 MASS 374 0.0267
506 GASTROENTERITIS 390 0.0267
507 TOOTH INFECTION 352 0.0267
508 RALES 155 0.0267
509 WHITE BLOOD CELL COUNT DECREASED 2886 0.0266
510 WEIGHT FLUCTUATION 277 0.0264
511 BLOOD PRESSURE INCREASED 4047 0.0264
512 TERMINAL STATE 176 0.0263
513 HEMIPARESIS 443 0.0261
514 DISSEMINATED INTRAVASCULAR COAGULATION 368 0.0261
515 DRUG INEFFECTIVE 34408 0.0261
516 COORDINATION ABNORMAL 362 0.0259
517 GENERALISED OEDEMA 321 0.0259
518 ATRIAL FIBRILLATION 2465 0.0253
519 HYPOPHOSPHATAEMIA 187 0.0253
520 RESPIRATORY TRACT CONGESTION 402 0.0253
521 CYSTITIS 799 0.0251
522 SARS-COV-2 TEST POSITIVE 331 0.0250
523 MIGRAINE 2380 0.0249
524 PLEURAL EFFUSION 1512 0.0248
525 ONYCHOCLASIS 171 0.0248
526 TRANSAMINASES INCREASED 550 0.0247
527 ACUTE RESPIRATORY FAILURE 475 0.0247
528 NEOPLASM PROGRESSION 849 0.0244
529 ORAL HERPES 474 0.0243
530 OSTEOMYELITIS 438 0.0242
531 DEEP VEIN THROMBOSIS 1564 0.0240
532 RASH MACULO-PAPULAR 535 0.0240
533 CHOLECYSTITIS ACUTE 136 0.0240
534 HYPOKALAEMIA 1105 0.0239
535 NEUROPATHY PERIPHERAL 2263 0.0238
536 BLOOD DISORDER 190 0.0237
537 MYOPATHY 204 0.0236
538 STAPHYLOCOCCAL INFECTION 778 0.0236
539 HEPATIC FAILURE 711 0.0236
540 ILEUS 291 0.0234
541 ATELECTASIS 226 0.0234
542 AFFECT LABILITY 225 0.0234
543 GRANULOCYTOPENIA 133 0.0233
544 CORONAVIRUS INFECTION 154 0.0233
545 ENTERITIS 149 0.0233
546 BLOOD CREATININE INCREASED 1517 0.0232
547 FUNGAL INFECTION 773 0.0232
548 CATARACT 1370 0.0230
549 PETECHIAE 240 0.0230
550 GASTROOESOPHAGEAL REFLUX DISEASE 1848 0.0229
551 LOCALISED INFECTION 549 0.0227
552 COLITIS 856 0.0226
553 EJECTION FRACTION DECREASED 350 0.0225
554 HEPATIC CYTOLYSIS 287 0.0225
555 BRONCHITIS 1665 0.0225
556 FATIGUE 17483 0.0224
557 FEAR OF INJECTION 160 0.0224
558 NERVE INJURY 249 0.0224
559 ODYNOPHAGIA 133 0.0223
560 PULMONARY EMBOLISM 2113 0.0222
561 FOETAL GROWTH RESTRICTION 135 0.0222
562 TOOTH DISORDER 492 0.0221
563 MALIGNANT MELANOMA 296 0.0221
564 ADVERSE EVENT 2034 0.0220
565 PURPURA 194 0.0219
566 FLUID RETENTION 1114 0.0219
567 SKIN LACERATION 238 0.0219
568 ATRIAL FLUTTER 172 0.0215
569 CHEST PAIN 3990 0.0215
570 TOOTH ABSCESS 219 0.0215
571 CHILLS 2506 0.0214
572 INTERVERTEBRAL DISC DEGENERATION 197 0.0213
573 MATERNAL EXPOSURE BEFORE PREGNANCY 145 0.0212
574 PHARYNGITIS 263 0.0212
575 LEUKOCYTOSIS 383 0.0211
576 BACK DISORDER 344 0.0211
577 HYPOXIA 744 0.0211
578 DRUG USE DISORDER 177 0.0210
579 AMNESIA 1369 0.0210
580 RASH PRURITIC 1140 0.0210
581 CELLULITIS 1058 0.0210
582 IMMUNE SYSTEM DISORDER 275 0.0208
583 SPINAL DISORDER 197 0.0208
584 SKIN REACTION 293 0.0208
585 REBOUND EFFECT 234 0.0207
586 GASTRIC DISORDER 708 0.0206
587 VITAMIN D DEFICIENCY 201 0.0206
588 TOOTH FRACTURE 227 0.0206
589 OPTIC NEURITIS 187 0.0206
590 LOW BIRTH WEIGHT BABY 163 0.0205
591 HAEMOGLOBIN DECREASED 2101 0.0204
592 HAEMATOCRIT DECREASED 404 0.0204
593 HEPATIC STEATOSIS 379 0.0203
594 HEART RATE INCREASED 2015 0.0203
595 TEMPERATURE INTOLERANCE 208 0.0201
596 ATRIOVENTRICULAR BLOCK COMPLETE 134 0.0200
597 POSTOPERATIVE WOUND INFECTION 135 0.0200
598 RASH ERYTHEMATOUS 949 0.0198
599 ADVERSE DRUG REACTION 1777 0.0198
600 PULMONARY CONGESTION 260 0.0197
601 ANGINA PECTORIS 565 0.0197
602 SKIN HAEMORRHAGE 292 0.0197
603 END STAGE RENAL DISEASE 359 0.0197
604 RENAL IMPAIRMENT 1649 0.0196
605 ECCHYMOSIS 133 0.0194
606 MEDICATION ERROR 1078 0.0194
607 HYPOCALCAEMIA 367 0.0194
608 ABDOMINAL PAIN UPPER 3987 0.0193
609 PARAESTHESIA 3046 0.0193
610 RESPIRATORY DISTRESS 531 0.0192
611 PEMPHIGOID 145 0.0192
612 PAIN IN EXTREMITY 5659 0.0192
613 HAEMODYNAMIC INSTABILITY 146 0.0191
614 DECREASED IMMUNE RESPONSIVENESS 188 0.0191
615 CHOLECYSTITIS 228 0.0191
616 THROAT TIGHTNESS 517 0.0191
617 OSTEOPENIA 290 0.0191
618 PRODUCTIVE COUGH 906 0.0190
619 ENCEPHALOPATHY 463 0.0188
620 ACUTE CORONARY SYNDROME 156 0.0188
621 ABSCESS 299 0.0187
622 WEIGHT DECREASED 5221 0.0187
623 DECREASED APPETITE 4338 0.0187
624 TENDONITIS 289 0.0186
625 DYSPNOEA 10563 0.0186
626 OEDEMA PERIPHERAL 2272 0.0186
627 NEURALGIA 453 0.0186
628 VOMITING 8748 0.0186
629 HAEMORRHAGE INTRACRANIAL 278 0.0186
630 RED BLOOD CELL COUNT DECREASED 530 0.0185
631 VIRAL INFECTION 616 0.0185
632 BLOOD IRON DECREASED 219 0.0184
633 ORAL DISORDER 135 0.0184
634 GAIT DISTURBANCE 3520 0.0184
635 ACUTE KIDNEY INJURY 2808 0.0183
636 COUGH 5142 0.0183
637 SHOCK HAEMORRHAGIC 148 0.0182
638 MYOCARDITIS 208 0.0181
639 MALAISE 7938 0.0181
640 ASCITES 532 0.0181
641 DENTAL CARIES 199 0.0180
642 KIDNEY INFECTION 353 0.0180
643 MALNUTRITION 201 0.0179
644 HYPERTENSIVE CRISIS 199 0.0179
645 DERMATITIS ALLERGIC 225 0.0179
646 LABORATORY TEST ABNORMAL 527 0.0178
647 URINARY TRACT INFECTION 3043 0.0178
648 CARDIAC FAILURE 1431 0.0178
649 NEPHROPATHY 166 0.0178
650 SINUS DISORDER 349 0.0176
651 ASTHENIA 6610 0.0176
652 HYPERBILIRUBINAEMIA 182 0.0176
653 HYPOTENSION 3510 0.0175
654 PNEUMOTHORAX 277 0.0174
655 MEMORY IMPAIRMENT 2383 0.0173
656 INFLUENZA 1932 0.0173
657 SNEEZING 384 0.0171
658 INJECTION SITE EXTRAVASATION 211 0.0171
659 ABDOMINAL PAIN 3963 0.0170
660 MULTI-ORGAN FAILURE 294 0.0170
661 LIVER FUNCTION TEST ABNORMAL 493 0.0169
662 IMPAIRED GASTRIC EMPTYING 231 0.0169
663 INJECTION SITE REACTION 1164 0.0169
664 FACIAL PARALYSIS 144 0.0169
665 PHARYNGEAL SWELLING 165 0.0168
666 PRURITUS 6477 0.0168
667 GLOMERULAR FILTRATION RATE DECREASED 207 0.0168
668 SKIN LESION 461 0.0168
669 SPUTUM DISCOLOURED 159 0.0167
670 MALIGNANT NEOPLASM PROGRESSION 1710 0.0167
671 NERVE COMPRESSION 154 0.0167
672 GASTRIC ULCER 315 0.0166
673 RESPIRATORY SYNCYTIAL VIRUS INFECTION 144 0.0165
674 RENAL CYST 131 0.0165
675 GINGIVAL BLEEDING 225 0.0165
676 HEPATIC ENCEPHALOPATHY 153 0.0164
677 BRAIN OEDEMA 207 0.0164
678 ELECTROLYTE IMBALANCE 190 0.0163
679 EYE INFECTION 184 0.0163
680 BLOOD TEST ABNORMAL 228 0.0162
681 HEADACHE 10138 0.0162
682 HEPATITIS C 195 0.0161
683 HEPATIC FUNCTION ABNORMAL 601 0.0161
684 INSOMNIA 4289 0.0161
685 ANKYLOSING SPONDYLITIS 212 0.0161
686 HAEMATURIA 549 0.0160
687 FREQUENT BOWEL MOVEMENTS 433 0.0160
688 CARDIOGENIC SHOCK 229 0.0159
689 OROPHARYNGEAL PAIN 1477 0.0159
690 UVEITIS 216 0.0159
691 NEPHROLITHIASIS 730 0.0159
692 DYSPNOEA EXERTIONAL 597 0.0158
693 SMALL INTESTINAL OBSTRUCTION 194 0.0157
694 HYPERGLYCAEMIA 574 0.0157
695 DYSPHAGIA 1491 0.0157
696 NEOPLASM MALIGNANT 1046 0.0157
697 HYPOTHYROIDISM 499 0.0156
698 BLOOD BILIRUBIN INCREASED 421 0.0156
699 BLOOD ALKALINE PHOSPHATASE INCREASED 387 0.0156
700 GLAUCOMA 300 0.0156
701 THROMBOSIS 1252 0.0155
702 FEELING HOT 949 0.0155
703 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 262 0.0154
704 RHINORRHOEA 990 0.0153
705 DIARRHOEA 9860 0.0153
706 PERITONITIS 316 0.0152
707 ORAL DISCOMFORT 212 0.0152
708 APHASIA 460 0.0152
709 RENAL TUBULAR NECROSIS 149 0.0152
710 IRON DEFICIENCY ANAEMIA 140 0.0152
711 TACHYCARDIA 1345 0.0151
712 PNEUMONIA ASPIRATION 378 0.0151
713 NERVOUS SYSTEM DISORDER 472 0.0151
714 NAUSEA 11843 0.0149
715 EOSINOPHILIA 262 0.0149
716 CHOLESTASIS 287 0.0149
717 DEPRESSION 3396 0.0149
718 IMPAIRED WORK ABILITY 319 0.0149
719 SPINAL OSTEOARTHRITIS 131 0.0149
720 OROPHARYNGEAL DISCOMFORT 134 0.0148
721 PERICARDIAL EFFUSION 342 0.0148
722 GASTROENTERITIS VIRAL 267 0.0148
723 DIABETES MELLITUS 1124 0.0147
724 RECTAL HAEMORRHAGE 626 0.0146
725 PHOTOSENSITIVITY REACTION 239 0.0145
726 SUBDURAL HAEMATOMA 207 0.0144
727 RENAL FAILURE 1919 0.0144
728 MUSCLE SPASMS 2646 0.0144
729 UNDERDOSE 1052 0.0144
730 LIMB DISCOMFORT 442 0.0143
731 EMPHYSEMA 144 0.0143
732 PANCREATITIS 751 0.0142
733 HERNIA 274 0.0142
734 HEPATOCELLULAR INJURY 199 0.0140
735 PARALYSIS 200 0.0140
736 HEPATOMEGALY 137 0.0139
737 OESOPHAGITIS 152 0.0139
738 PREMATURE DELIVERY 221 0.0139
739 TACHYPNOEA 186 0.0137
740 EATING DISORDER 291 0.0137
741 BONE DISORDER 249 0.0137
742 NASAL CONGESTION 800 0.0136
743 CENTRAL NERVOUS SYSTEM LESION 187 0.0136
744 EYE DISORDER 447 0.0136
745 SLEEP APNOEA SYNDROME 259 0.0136
746 ABDOMINAL DISTENSION 1409 0.0135
747 SUBARACHNOID HAEMORRHAGE 136 0.0133
748 ARRHYTHMIA 631 0.0133
749 PREMATURE BABY 401 0.0133
750 ORAL PAIN 298 0.0133
751 ATAXIA 157 0.0132
752 HYPOMAGNESAEMIA 183 0.0131
753 ROTATOR CUFF SYNDROME 168 0.0131
754 CHEST DISCOMFORT 1338 0.0131
755 ASPIRATION 143 0.0130
756 PSORIASIS 1689 0.0129
757 GAMMA-GLUTAMYLTRANSFERASE INCREASED 286 0.0129
758 SPINAL FRACTURE 258 0.0129
759 ERYTHEMA 2641 0.0128
760 BACK PAIN 2956 0.0127
761 DERMATITIS 266 0.0127
762 GOUT 227 0.0126
763 BLOOD URINE PRESENT 240 0.0126
764 BRONCHOSPASM 180 0.0126
765 DYSARTHRIA 473 0.0126
766 HYPERKALAEMIA 440 0.0125
767 GASTRITIS 330 0.0125
768 THYROID DISORDER 193 0.0125
769 ACUTE MYOCARDIAL INFARCTION 367 0.0124
770 LIMB INJURY 338 0.0124
771 BLOOD UREA INCREASED 208 0.0124
772 PULMONARY OEDEMA 556 0.0124
773 COAGULOPATHY 206 0.0124
774 HIATUS HERNIA 160 0.0123
775 SYNCOPE 1230 0.0123
776 FOETAL EXPOSURE DURING PREGNANCY 999 0.0123
777 HYPONATRAEMIA 692 0.0123
778 COLON CANCER 183 0.0123
779 HAEMORRHAGE 1283 0.0123
780 CONJUNCTIVITIS 227 0.0122
781 CARPAL TUNNEL SYNDROME 171 0.0122
782 TOOTHACHE 219 0.0121
783 NO THERAPEUTIC RESPONSE 147 0.0120
784 TOXIC EPIDERMAL NECROLYSIS 183 0.0120
785 PULMONARY HYPERTENSION 251 0.0120
786 MYOCARDIAL ISCHAEMIA 137 0.0120
787 HYPERHIDROSIS 1549 0.0120
788 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 309 0.0120
789 PAIN IN JAW 340 0.0120
790 FOOT FRACTURE 225 0.0119
791 FEELING COLD 330 0.0118
792 SINUS TACHYCARDIA 168 0.0118
793 PARAESTHESIA ORAL 170 0.0118
794 ISCHAEMIC STROKE 209 0.0117
795 COLITIS ULCERATIVE 523 0.0117
796 BONE PAIN 682 0.0116
797 PHARYNGEAL OEDEMA 179 0.0116
798 BLOOD PRESSURE DECREASED 753 0.0113
799 RENAL DISORDER 523 0.0112
800 DIZZINESS 5545 0.0111
801 COGNITIVE DISORDER 519 0.0111
802 GASTROINTESTINAL HAEMORRHAGE 926 0.0111
803 HEART RATE IRREGULAR 250 0.0111
804 MUSCLE ATROPHY 140 0.0110
805 DEAFNESS 288 0.0110
806 VISUAL IMPAIRMENT 1363 0.0110
807 MUSCULOSKELETAL CHEST PAIN 170 0.0110
808 FALL 3650 0.0110
809 HYPOAESTHESIA ORAL 165 0.0109
810 SKIN CANCER 234 0.0109
811 HAEMOPTYSIS 303 0.0109
812 TUBULOINTERSTITIAL NEPHRITIS 203 0.0108
813 RIB FRACTURE 222 0.0108
814 EYE HAEMORRHAGE 144 0.0108
815 HAEMATOMA 279 0.0108
816 CYST 133 0.0107
817 CEREBRAL INFARCTION 259 0.0106
818 INTERVERTEBRAL DISC PROTRUSION 230 0.0105
819 DIPLOPIA 273 0.0105
820 INFLUENZA LIKE ILLNESS 863 0.0105
821 BLINDNESS 425 0.0104
822 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 543 0.0104
823 APHONIA 145 0.0104
824 QUALITY OF LIFE DECREASED 139 0.0103
825 UPPER GASTROINTESTINAL HAEMORRHAGE 173 0.0103
826 BEDRIDDEN 135 0.0103
827 MENTAL STATUS CHANGES 283 0.0102
828 DRY EYE 508 0.0102
829 DIABETES MELLITUS INADEQUATE CONTROL 180 0.0102
830 SKIN DISORDER 338 0.0101
831 RESTLESS LEGS SYNDROME 183 0.0101
832 PALLOR 270 0.0099
833 CONSTIPATION 2154 0.0099
834 SEASONAL ALLERGY 139 0.0098
835 JAUNDICE 264 0.0098
836 TOXICITY TO VARIOUS AGENTS 1651 0.0098
837 PRESYNCOPE 238 0.0098
838 MUSCULOSKELETAL DISCOMFORT 168 0.0098
839 DRUG EFFECT INCOMPLETE 353 0.0097
840 ANKLE FRACTURE 150 0.0097
841 PRODUCT PRESCRIBING ERROR 230 0.0096
842 GALLBLADDER DISORDER 172 0.0096
843 CARDIAC ARREST 792 0.0096
844 ANXIETY 2729 0.0096
845 PALPITATIONS 1120 0.0096
846 FLUSHING 971 0.0095
847 ANAPHYLACTIC SHOCK 246 0.0095
848 SHOCK 219 0.0095
849 DEHYDRATION 1268 0.0095
850 CARDIOVASCULAR DISORDER 240 0.0094
851 EPISTAXIS 705 0.0094
852 LOSS OF CONSCIOUSNESS 1205 0.0094
853 PHOTOPHOBIA 176 0.0093
854 DEATH 8019 0.0093
855 FEMUR FRACTURE 288 0.0093
856 CARDIAC DISORDER 869 0.0093
857 DYSPHONIA 538 0.0092
858 LUNG NEOPLASM MALIGNANT 378 0.0092
859 MELAENA 202 0.0092
860 PANCREATITIS ACUTE 206 0.0092
861 MOVEMENT DISORDER 293 0.0091
862 DRUG EFFECT DECREASED 489 0.0091
863 BLOOD PRESSURE ABNORMAL 180 0.0090
864 VENTRICULAR TACHYCARDIA 149 0.0090
865 OSTEONECROSIS 296 0.0090
866 CEREBRAL HAEMORRHAGE 321 0.0090
867 HAEMORRHOIDS 171 0.0088
868 STEVENS-JOHNSON SYNDROME 194 0.0087
869 MULTIPLE SCLEROSIS 415 0.0087
870 FEEDING DISORDER 176 0.0087
871 CHOLELITHIASIS 284 0.0087
872 INTENTIONAL PRODUCT MISUSE 749 0.0085
873 THERAPEUTIC RESPONSE SHORTENED 283 0.0085
874 BLOOD POTASSIUM DECREASED 253 0.0084
875 COLD SWEAT 148 0.0084
876 BRADYCARDIA 444 0.0084
877 HYPOPHAGIA 213 0.0083
878 BLOOD SODIUM DECREASED 157 0.0083
879 BALANCE DISORDER 716 0.0083
880 PRODUCT PRESCRIBING ISSUE 179 0.0082
881 PSYCHOTIC DISORDER 242 0.0082
882 SCAR 137 0.0080
883 DYSURIA 294 0.0080
884 TOOTH LOSS 165 0.0080
885 INTESTINAL OBSTRUCTION 299 0.0079
886 CARDIAC FAILURE CONGESTIVE 637 0.0079
887 FACE OEDEMA 132 0.0078
888 ANGIOEDEMA 343 0.0077
889 MYALGIA 1313 0.0077
890 TINNITUS 350 0.0076
891 RETCHING 162 0.0076
892 CORONARY ARTERY DISEASE 229 0.0076
893 FRACTURE 143 0.0075
894 UPPER LIMB FRACTURE 149 0.0075
895 TREATMENT NONCOMPLIANCE 407 0.0074
896 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1334 0.0074
897 RENAL FAILURE ACUTE 310 0.0073
898 HOT FLUSH 550 0.0073
899 URINARY INCONTINENCE 215 0.0072
900 PRODUCT QUALITY ISSUE 979 0.0072
901 ILLNESS 739 0.0072
902 URINARY RETENTION 238 0.0071
903 SEIZURE 820 0.0071
904 ABDOMINAL PAIN LOWER 176 0.0070
905 POOR QUALITY SLEEP 149 0.0069
906 MYOCARDIAL INFARCTION 1205 0.0069
907 LETHARGY 390 0.0068
908 BONE DENSITY DECREASED 210 0.0067
909 TREMOR 1108 0.0067
910 CEREBROVASCULAR ACCIDENT 1128 0.0067
911 HIP FRACTURE 213 0.0066
912 ALTERED STATE OF CONSCIOUSNESS 140 0.0065
913 LACRIMATION INCREASED 195 0.0064
914 SOMNOLENCE 1285 0.0064
915 DYSSTASIA 185 0.0063
916 BLOOD CREATINE PHOSPHOKINASE INCREASED 182 0.0063
917 SWELLING FACE 410 0.0063
918 VERTIGO 383 0.0063
919 COMA 296 0.0062
920 MUSCLE TWITCHING 143 0.0062
921 TRANSIENT ISCHAEMIC ATTACK 209 0.0062
922 LACTIC ACIDOSIS 196 0.0060
923 BURNING SENSATION 422 0.0060
924 DRUG INTERACTION 950 0.0060
925 SKIN DISCOLOURATION 268 0.0058
926 METABOLIC ACIDOSIS 180 0.0056
927 UNEVALUABLE EVENT 425 0.0056
928 POLLAKIURIA 232 0.0056
929 SKIN EXFOLIATION 459 0.0054
930 HAEMATOCHEZIA 298 0.0054
931 MULTIPLE SCLEROSIS RELAPSE 370 0.0054
932 CHRONIC KIDNEY DISEASE 409 0.0054
933 RASH MACULAR 188 0.0054
934 EYE SWELLING 200 0.0054
935 HYPOACUSIS 230 0.0053
936 OVERDOSE 1130 0.0052
937 GLYCOSYLATED HAEMOGLOBIN INCREASED 132 0.0052
938 MENTAL DISORDER 227 0.0052
939 EYE PAIN 292 0.0052
940 HAEMATEMESIS 131 0.0052
941 CARDIO-RESPIRATORY ARREST 212 0.0051
942 DEMENTIA 141 0.0050
943 SWOLLEN TONGUE 157 0.0050
944 BREAST CANCER 456 0.0049
945 HOSPITALISATION 750 0.0049
946 DEPRESSED MOOD 256 0.0048
947 SPEECH DISORDER 250 0.0048
948 HYPOGLYCAEMIA 231 0.0048
949 EYE PRURITUS 160 0.0048
950 DEPRESSED LEVEL OF CONSCIOUSNESS 187 0.0047
951 FEELING ABNORMAL 1113 0.0046
952 PROSTATE CANCER 366 0.0045
953 ECZEMA 238 0.0045
954 LIP SWELLING 150 0.0045
955 HEAD INJURY 142 0.0045
956 DISORIENTATION 177 0.0045
957 EMOTIONAL DISORDER 137 0.0044
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 146 0.0043
959 BLOOD GLUCOSE INCREASED 803 0.0043
960 OCULAR HYPERAEMIA 202 0.0043
961 DISTURBANCE IN ATTENTION 225 0.0042
962 ELECTROCARDIOGRAM QT PROLONGED 148 0.0041
963 VISUAL ACUITY REDUCED 136 0.0041
964 ABORTION SPONTANEOUS 164 0.0041
965 RESTLESSNESS 148 0.0040
966 VISION BLURRED 540 0.0039
967 CRYING 141 0.0039
968 NERVOUSNESS 197 0.0038
969 ACNE 265 0.0035
970 AGITATION 253 0.0034
971 DYSGEUSIA 246 0.0033
972 HALLUCINATION 245 0.0032
973 EYE IRRITATION 170 0.0030
974 BLOOD GLUCOSE DECREASED 136 0.0028
975 PRODUCT DOSE OMISSION ISSUE 814 0.0028
976 CONVULSION 157 0.0027
977 DRY SKIN 349 0.0026
978 FLATULENCE 140 0.0025
979 SURGERY 142 0.0024
980 DRUG DEPENDENCE 339 0.0021
981 INJECTION SITE BRUISING 167 0.0021
982 PRODUCT STORAGE ERROR 169 0.0019
983 SUICIDAL IDEATION 166 0.0018
984 INJECTION SITE ERYTHEMA 192 0.0015
985 INCORRECT DOSE ADMINISTERED 319 0.0014
986 INJECTION SITE PAIN 356 0.0012
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 195 0.0010
988 DRUG DOSE OMISSION 134 0.0008